BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

900 related articles for article (PubMed ID: 34492394)

  • 1. Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database.
    Sato K; Mano T; Niimi Y; Toda T; Iwata A; Iwatsubo T
    Int J Infect Dis; 2021 Oct; 111():310-312. PubMed ID: 34492394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study.
    Wan EYF; Chui CSL; Lai FTT; Chan EWY; Li X; Yan VKC; Gao L; Yu Q; Lam ICH; Chun RKC; Cowling BJ; Fong WC; Lau AYL; Mok VCT; Chan FLF; Lee CK; Chan LST; Lo D; Lau KK; Hung IFN; Leung GM; Wong ICK
    Lancet Infect Dis; 2022 Jan; 22(1):64-72. PubMed ID: 34411532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance.
    Ruggiero R; Balzano N; Di Napoli R; Mascolo A; Berrino PM; Rafaniello C; Sportiello L; Rossi F; Capuano A
    Front Immunol; 2022; 13():956825. PubMed ID: 36177033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to "Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database" by Sato et al.
    O'Fee JR; Li J; Chang JR
    Int J Infect Dis; 2022 Mar; 116():10. PubMed ID: 34954309
    [No Abstract]   [Full Text] [Related]  

  • 5. Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination With BNT162b2 Increased Risk of Bell's Palsy: A Nested Case-Control and Self-Controlled Case Series Study.
    Wan EYF; Chui CSL; Ng VWS; Wang Y; Yan VKC; Lam ICH; Fan M; Lai FTT; Chan EWY; Li X; Wong CKH; Chung RKC; Cowling BJ; Fong WC; Lau AYL; Mok VCT; Chan FLF; Lee CK; Chan LST; Lo D; Lau KK; Hung IFN; Lau CS; Leung GM; Wong ICK
    Clin Infect Dis; 2023 Feb; 76(3):e291-e298. PubMed ID: 35675702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facial paralysis and vaccinations: a vaccine adverse event reporting system review.
    Ahsanuddin S; Nasser W; Roy SC; Povolotskiy R; Paskhover B
    Fam Pract; 2022 Jan; 39(1):80-84. PubMed ID: 34184737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; DeStefano F; Iskander JK; Haber P; Chen RT;
    Pharmacoepidemiol Drug Saf; 2004 Aug; 13(8):505-10. PubMed ID: 15317028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-life safety profile of mRNA vaccines for COVID-19: An analysis of VAERS database.
    Santi Laurini G; Montanaro N; Broccoli M; Bonaldo G; Motola D
    Vaccine; 2023 May; 41(18):2879-2886. PubMed ID: 37024412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hearing disorder following COVID-19 vaccination: A pharmacovigilance analysis using the Vaccine Adverse Event Reporting System.
    Chen C; Fu F; Ding L; Xiao J
    J Clin Pharm Ther; 2022 Nov; 47(11):1789-1795. PubMed ID: 36089844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines and Bell's palsy: A narrative review.
    Bertin B; Grenet G; Pizzoglio-Billaudaz V; Lepelley M; Atzenhoffer M; Vial T
    Therapie; 2023; 78(3):279-292. PubMed ID: 36038397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative safety of mRNA COVID-19 vaccines to influenza vaccines: A pharmacovigilance analysis using WHO international database.
    Kim MS; Jung SY; Ahn JG; Park SJ; Shoenfeld Y; Kronbichler A; Koyanagi A; Dragioti E; Tizaoui K; Hong SH; Jacob L; Salem JE; Yon DK; Lee SW; Ogino S; Kim H; Kim JH; Excler JL; Marks F; Clemens JD; Eisenhut M; Barnett Y; Butler L; Ilie CP; Shin EC; Il Shin J; Smith L
    J Med Virol; 2022 Mar; 94(3):1085-1095. PubMed ID: 34709664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Otolaryngologic Side Effects After COVID-19 Vaccination.
    Ahsanuddin S; Jin R; Dhanda AK; Georges K; Baredes S; Eloy JA; Fang CH
    Laryngoscope; 2024 Mar; 134(3):1163-1168. PubMed ID: 37539984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis.
    Li X; Raventós B; Roel E; Pistillo A; Martinez-Hernandez E; Delmestri A; Reyes C; Strauss V; Prieto-Alhambra D; Burn E; Duarte-Salles T
    BMJ; 2022 Mar; 376():e068373. PubMed ID: 35296468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform.
    Walker JL; Schultze A; Tazare J; Tamborska A; Singh B; Donegan K; Stowe J; Morton CE; Hulme WJ; Curtis HJ; Williamson EJ; Mehrkar A; Eggo RM; Rentsch CT; Mathur R; Bacon S; Walker AJ; Davy S; Evans D; Inglesby P; Hickman G; MacKenna B; Tomlinson L; Ca Green A; Fisher L; Cockburn J; Parry J; Hester F; Harper S; Bates C; Evans SJ; Solomon T; Andrews NJ; Douglas IJ; Goldacre B; Smeeth L; McDonald HI
    Vaccine; 2022 Jul; 40(32):4479-4487. PubMed ID: 35715350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of Simultaneous Administration of Bivalent mRNA COVID-19 and Influenza Vaccines in the Vaccine Adverse Event Reporting System (VAERS).
    Moro PL; Ennulat C; Brown H; Woody G; Zhang B; Marquez P; Woo EJ; Su JR
    Drug Saf; 2024 May; 47(5):487-493. PubMed ID: 38411838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021-June 30, 2022.
    Moro PL; Zhang B; Ennulat C; Harris M; McVey R; Woody G; Marquez P; McNeil MM; Su JR
    Vaccine; 2023 Mar; 41(11):1859-1863. PubMed ID: 36669964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bell's Palsy After Vaccination Against Covid-19: A Systematic Review and Meta-analysis.
    Gordon AJ; Varelas A; Eytan DF
    Otolaryngol Head Neck Surg; 2023 Nov; 169(5):1114-1121. PubMed ID: 37272720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observed-over-Expected analysis as additional method for pharmacovigilance signal detection in large-scaled spontaneous adverse event reporting.
    van der Boom MDX; van Eekeren R; van Hunsel FPAM
    Pharmacoepidemiol Drug Saf; 2023 Jul; 32(7):783-794. PubMed ID: 36919526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative safety profile of bivalent and original COVID-19 mRNA vaccines regarding myocarditis/pericarditis: A pharmacovigilance study.
    Chen C; Chen C; Cao L; Fang J; Xiao J
    Int Immunopharmacol; 2024 May; 133():112022. PubMed ID: 38615382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facial Paralysis Following Influenza Vaccination: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System Database.
    Kamath A; Maity N; Nayak MA
    Clin Drug Investig; 2020 Sep; 40(9):883-889. PubMed ID: 32696320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.